Skip to main content
UniHealth

Doctor search

Peter R Carroll, MD

Urology · Berkeley

NPI 1366461667

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
12
2 carriers
Offices
3
Since medical school
47 years
Georgetown University School of Medicine, 1979

Offices

3 locations · UCSF Medical Group Business Services · 1,533 clinicians in this group

Looking this up.

Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.

Plans that list them

12 plans · 2 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Carroll’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

12 of 12 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Imperial Courage Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Dynamic Plan (HMO)Imperial Health Plan of California, Inc.ListedSep 1, 2026
Imperial Senior Value (HMO C-SNP)Imperial Health Plan of California, Inc.ListedSep 1, 2026

California Medical Board record

Licence A35750 · Current

Licensed to practise in California · since 1980 · expires 2027-12-31 · Georgetown University School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Urology - Urology

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UCSF Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.9 (3.79 to 6.02) · 7,590 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.8 (11.3 to 14.4) · 2,019 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths139.4 (110.22 to 168.58) · 452 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.622BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.626BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.491BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,336 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.24 (0.58 to 1.9) · 4,689 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.89 to 1.2)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.5 · 85 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.1 · 132 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.6 · 454 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 618 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 380 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 5,000 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.06 to 0.38) · 15,965 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.05 to 0.35) · 17,859 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.85 (0 to 1.83) · 4,184 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2 (1.1 to 2.9) · 6,516 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.35 (4.49 to 10.21) · 3,989 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5 (3.22 to 6.77) · 4,087 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.95 (0.74 to 3.15) · 2,034 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.63 to 1.28) · 15,431 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 399 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.899No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.689No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.224No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16 · 156 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20 · 564 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits60.3 · 160 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-9.7 · 550 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits44.1 · 660 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 667 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (4.8 to 6.7) · 2,019 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6 · 421 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 107 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.9 (11.3 to 17.1) · 3,247 casesNo differentJan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Patient survey stars by topic at UCSF Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at UCSF Medical Center
Room was "always" clean71%
Nurses "always" communicated well80%
Doctors "always" communicated well80%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully78%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital81%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$111,293

Medicare paid this office $111,293 for 433 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Surgical removal of prostate and surrounding lymph nodes using an endoscope48$50,180$1,045
Return visit (30+ min)186$19,453$83
New patient visit (45+ min)100$10,817$108
Short return visit (20+ min)136$8,545$54
New patient visit (30+ min)86$5,064$59
See all 9 services
Every Original Medicare service billed
Surgical removal of prostate and surrounding lymph nodes using an endoscope48$50,180$1,045
Return visit (30+ min)186$19,453$83
New patient visit (45+ min)100$10,817$108
Short return visit (20+ min)136$8,545$54
New patient visit (30+ min)86$5,064$59
Removal of lymph nodes of both sides of pelvis using an endoscope16$4,507$282
Diagnostic exam of bladder and urethra using an endoscope44$3,629$67
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's162$3,049$15
Telephone medical discussion with physician, 21-30 minutes16$1,325$78

Procedures Medicare counted

Procedure volume Medicare published
Prostate resection26More than 87% of doctors who do this

Procedures year by year

Procedures billed to Original Medicare by year
Procedure201920202021202220232024
Diagnostic exam of bladder and urethra using an endoscope747591818554
Surgical removal of prostate and surrounding lymph nodes using an endoscope796867736948
Removal of lymph nodes of both sides of pelvis using an endoscope441618–1816

Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.

Who their Medicare patients are

433 Original Medicare patients in 2024. Average age 74 · Also on Medicaid 5% · Health risk score 0.92. At or below the middle of the specialty; the typical urology clinician is at 1.36.

Conditions among them: Cancer 75% · High blood pressure 63% · Coronary heart disease 31% · Diabetes 16% · Chronic kidney disease 15% · Atrial fibrillation 15% · Depression 7% · Heart failure 6% · COPD 4% · Stroke 3%.

The office billed $1,016,025, Medicare allowed $145,106 and paid $111,293; for 977 services of 28 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024433977740.92$1,016,025$111,293
2023425727730.85$1,172,415$120,419
2022433746740.83$1,165,246$136,774
2021454794730.84$1,241,311$146,969
2020408762730.87$1,234,471$143,137
2019414663730.83$1,362,715$153,232
2018378614730.83$1,334,417$144,771
2017379670730.84$1,361,699$145,378
2016393707720.84$1,479,232$163,530
2015458883720.83$2,088,147$258,759
2014384750720.87$1,377,026$175,591
2013400817720.80$1,365,037$170,870

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 8 services

Original Medicare services billed in 2023
Surgical removal of prostate and surrounding lymph nodes using an endoscope69$72,631$1,053
Short return visit (20+ min)218$15,628$54
New patient visit (30+ min)142$9,523$67
Diagnostic exam of bladder and urethra using an endoscope64$5,395$63
Removal of lymph nodes of both sides of pelvis using an endoscope18$5,321$296
Return visit (30+ min)53$4,512$82
New patient visit (45+ min)15$1,792$119
Telephone medical discussion with physician, 21-30 minutes13$1,063$76

2022: 6 services

Original Medicare services billed in 2022
Surgical removal of prostate and surrounding lymph nodes using an endoscope73$91,634$1,255
Short return visit (20+ min)238$17,734$53
New patient visit (30+ min)162$10,631$66
Diagnostic exam of bladder and urethra using an endoscope57$5,568$69
Return visit (30+ min)31$2,305$70
Telephone medical discussion with physician, 11-20 minutes12$648$54

2021: 9 services

Original Medicare services billed in 2021
Surgical removal of prostate and surrounding lymph nodes using an endoscope67$86,786$1,295
Return visit (30+ min)120$12,291$86
Short return visit (20+ min)161$12,182$58
New patient visit (45+ min)92$9,969$108
New patient visit (30+ min)93$6,544$70
Diagnostic exam of bladder and urethra using an endoscope62$6,091$67
Removal of lymph nodes of both sides of pelvis using an endoscope18$5,429$302
Telephone medical discussion with physician, 21-30 minutes23$1,946$85
Telephone medical discussion with physician, 11-20 minutes16$918$54

2020: 10 services

Original Medicare services billed in 2020
Surgical removal of prostate and surrounding lymph nodes using an endoscope68$89,356$1,314
Short return visit (20+ min)159$8,834$43
Return visit (30+ min)105$8,723$70
New patient visit (45+ min)49$5,575$114
New patient visit (30+ min)87$5,523$63
Diagnostic exam of bladder and urethra using an endoscope55$4,896$65
Removal of lymph nodes of both sides of pelvis using an endoscope16$4,471$279
Telephone medical discussion with physician, 11-20 minutes29$1,648$47
New patient visit (15+ min)28$775$28
Telephone medical discussion with physician, 21-30 minutes11$719$65

2019: 8 services

Original Medicare services billed in 2019
Surgical removal of prostate and surrounding lymph nodes using an endoscope79$102,909$1,303
Removal of lymph nodes of both sides of pelvis using an endoscope44$13,197$300
Return visit (30+ min)118$8,562$65
New patient visit (30+ min)118$7,469$63
Short return visit (20+ min)105$4,947$41
Diagnostic exam of bladder and urethra using an endoscope49$4,755$64
New patient visit (45+ min)23$2,495$108
New patient visit (15+ min)27$1,187$44

2018: 8 services

Original Medicare services billed in 2018
Surgical removal of prostate and surrounding lymph nodes using an endoscope75$98,017$1,290
Removal of lymph nodes of both sides of pelvis using an endoscope52$15,283$294
Return visit (30+ min)82$5,858$65
Short return visit (20+ min)126$5,536$39
New patient visit (30+ min)73$4,763$65
Diagnostic exam of bladder and urethra using an endoscope49$4,028$66
New patient visit (15+ min)41$1,377$34
Long return visit (40+ min)11$1,035$94

2017: 10 services

Original Medicare services billed in 2017
Surgical removal of prostate and surrounding lymph nodes using an endoscope69$89,649$1,299
Removal of lymph nodes of both sides of pelvis using an endoscope47$14,185$302
Return visit (30+ min)115$8,492$62
Other procedure on male genital system27$7,220$267
Diagnostic exam of bladder and urethra using an endoscope51$6,016$82
Short return visit (20+ min)127$5,422$38
New patient visit (30+ min)42$2,154$51
New patient visit (15+ min)45$1,783$40
Long return visit (40+ min)13$1,193$92
Short return visit15$295$18

2016: 11 services

Original Medicare services billed in 2016
Surgical removal of prostate and surrounding lymph nodes using an endoscope70$91,226$1,303
Removal of lymph nodes of both sides of pelvis using an endoscope50$15,261$305
Other procedure on male genital system23$7,869$342
Return visit (30+ min)99$7,724$67
New patient visit (45+ min)55$6,295$114
Short return visit (20+ min)129$6,295$42
Diagnostic exam of bladder and urethra using an endoscope46$6,271$103
Creation of sling around urethra in male to control leakage17$5,788$340
New patient visit (60+ min)23$3,304$144
New patient visit (30+ min)50$3,299$66
Short return visit27$511$18

2015: 10 services

Original Medicare services billed in 2015
Surgical removal of prostate and surrounding lymph nodes using an endoscope100$156,237$1,562
Creation of sling around urethra in male to control leakage71$24,398$344
Removal of lymph nodes of both sides of pelvis using an endoscope56$20,124$359
Short return visit (20+ min)210$11,293$42
Diagnostic exam of bladder and urethra using an endoscope56$8,220$107
New patient visit (45+ min)60$6,580$110
Return visit (30+ min)77$5,102$64
New patient visit (30+ min)35$2,190$63
New patient visit (15+ min)32$1,354$42
Short return visit28$526$19

2014: 11 services

Original Medicare services billed in 2014
Surgical removal of prostate and surrounding lymph nodes using an endoscope63$96,914$1,538
Removal of lymph nodes of both sides of pelvis using an endoscope26$9,221$355
Short return visit (20+ min)166$9,112$43
Diagnostic exam of bladder and urethra using an endoscope53$7,784$105
Creation of sling around urethra in male to control leakage19$6,465$340
New patient visit (45+ min)25$2,834$113
Return visit (30+ min)41$2,810$65
New patient visit (30+ min)36$2,374$66
New patient visit (15+ min)25$1,077$43
Short return visit47$881$18
Office for the evaluation and management of established patient that may not require presence of healthcare professional66$588$7

2013: 13 services

Original Medicare services billed in 2013
Surgical removal of prostate and surrounding lymph nodes using an endoscope68$102,016$1,500
Removal of lymph nodes of both sides of pelvis using an endoscope30$10,232$341
Creation of sling around urethra in male to control leakage26$8,594$331
Diagnostic exam of bladder and urethra using an endoscope56$8,254$104
Short return visit (20+ min)158$8,066$41
Return visit (30+ min)47$3,093$63
New patient visit (30+ min)48$2,971$62
Destruction and/or removal of growth of bladder and urethra using an endoscope, 0.5-2.0 cm11$2,762$212
New patient visit (15+ min)52$2,055$40
New patient visit (45+ min)14$1,585$113
Short return visit47$1,127$19
Office for the evaluation and management of established patient that may not require presence of healthcare professional46$509$8
New patient visit (10+ min)19$438$23

Drugs they prescribed that Part D paid

$1,839

Pharmacies billed $1,839 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 93) in 2024. At or below the middle of the specialty; the typical urology clinician is at 2%.

92 generic and fewer than 11 brand-name prescriptions · $1,839 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Tamsulosin56$615$11
Dutasteride11$192$17

Year by year

Part D prescribing by year
202493330% (0)None$1,839
202359210% (0)None$2,969
202262230% (0)None$4,239
202142180% (0)31%$7,984
202081330% (0)None$1,642
201912647NoneNone$4,241
201814457None13%$9,379
201722070NoneNone$6,027
201619570None12%$8,789
2015300764% (13)None$13,313
201420066NoneNone$12,989
201321367NoneNone$16,659

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 2 drugs

Part D drugs prescribed in 2023
Tamsulosin25$899$36
Dutasteride18$717$40

2022: 2 drugs

Part D drugs prescribed in 2022
Tamsulosin15$462$31
Dutasteride16$461$29

2021: 1 drug

Part D drugs prescribed in 2021
Myrbetriq13$7,054$543

2020: 1 drug

Part D drugs prescribed in 2020
Tamsulosin25$231$9

2019: 4 drugs

Part D drugs prescribed in 2019
Tamsulosin35$494$14
Pentoxifylline15$339$23
Sulfamethoxazole-Trimethoprim11$23$2
Cephalexin11$16$1

2018: 4 drugs

Part D drugs prescribed in 2018
Cialis11$4,070$370
Tamsulosin25$538$22
Pentoxifylline18$384$21
Finasteride13$82$6

2017: 7 drugs

Part D drugs prescribed in 2017
Pentoxifylline38$1,016$27
Tamsulosin31$704$23
Finasteride32$426$13
Oxybutynin Chloride12$254$21
Dutasteride13$186$14
Sulfamethoxazole-Trimethoprim19$122$6
Cephalexin13$48$4

2016: 5 drugs

Part D drugs prescribed in 2016
Cialis16$4,113$257
Tamsulosin32$782$24
Pentoxifylline38$652$17
Finasteride37$458$12
Oxybutynin Chloride11$212$19

2015: 7 drugs

Part D drugs prescribed in 2015
Vesicare14$3,493$250
Tamsulosin55$1,294$24
Pentoxifylline50$1,037$21
Finasteride47$429$9
Bicalutamide11$240$22
Oxybutynin Chloride14$189$13
Ciprofloxacin20$79$4

2014: 6 drugs

Part D drugs prescribed in 2014
Avodart38$9,045$238
Tamsulosin42$702$17
Pentoxifylline13$391$30
Finasteride34$330$10
Sodium Chloride11$282$26
Ciprofloxacin13$52$4

2013: 7 drugs

Part D drugs prescribed in 2013
Avodart33$6,634$201
Tamsulosin36$695$19
Finasteride28$660$24
Pentoxifylline24$632$26
Sodium Chloride11$182$17
Oxybutynin Chloride11$104$9
Ciprofloxacin14$52$4

Money from drug and device companies

$3,330 in 2025

Industry payments by year
202544$1,200$3,330
202426$1,908$2,187
202311None$95
202034$6,250$6,276
2019410$6,864$17,913

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Intuitive SurgicalDa Vinci Surgical System$2,000
1 payment
  • Education for Da Vinci Surgical System · 2025-11-19 · $2,000
TolmarNone$1,200
1 payment
  • Consulting · 2025-05-30 · $1,200
Janssen BiotechErleada$100
1 payment
  • Education for Erleada · 2025-11-10 · $100
KoelisTrinity$30
1 payment
  • Meals for Trinity · 2025-10-29 · $30
See all 4 published payments
Every published payment
Intuitive SurgicalEducation · 2025-11-19Da Vinci Surgical System$2,000
Janssen BiotechEducation · 2025-11-10Erleada$100
KoelisMeals · 2025-10-29Trinity$30
TolmarConsulting · 2025-05-30None$1,200
See earlier years (2024, 2023, 2020, 2019)

2024: $2,187

Payments by company in 2024
Janssen Scientific AffairsErleada$2,028
2 payments
  • Consulting for Erleada · 2024-06-28 · $1,908
  • Meals for Erleada · 2024-06-13 · $120
Intuitive SurgicalDa Vinci Surgical System$159
4 payments
  • Meals for Da Vinci Surgical System · 2024-02-27 · $58
  • Meals for Da Vinci Surgical System · 2024-02-27 · $56
  • Meals for Da Vinci Surgical System · 2024-02-27 · $24
  • Meals for Da Vinci Surgical System · 2024-02-27 · $21

2023: $95

Payments by company in 2023
Intuitive SurgicalDa Vinci Surgical System$95
1 payment
  • Gift for Da Vinci Surgical System · 2023-04-25 · $95

2020: $6,276

Payments by company in 2020
InSightecNone$4,000
2 payments
  • Consulting · 2020-08-26 · $2,000
  • Consulting · 2020-06-04 · $2,000
Progenics PharmaceuticalsNone$2,250
1 payment
  • Paid to speak or teach · 2020-07-02 · $2,250
Intuitive SurgicalDa Vinci Surgical System$26
1 payment
  • Meals for Da Vinci Surgical System · 2020-08-12 · $26

2019: $17,913

Payments by company in 2019
Chugai Pharmaceutical Co.Non-Covered Product$12,199
3 payments
  • Consulting for Non-Covered Product · 2019-02-10 · $3,364
  • Travel for Non-Covered Product · 2019-02-10 · $8,102
  • Travel for Non-Covered Product · 2019-02-10 · $733
InSightecNone$4,274
2 payments
  • Consulting · 2019-07-17 · $3,500
  • Travel · 2019-07-17 · $774
InSightecNone$966
1 payment
  • Travel · 2019-07-17 · $966
Intuitive SurgicalDa Vinci Surgical System$474
3 payments
  • Meals for Da Vinci Surgical System · 2019-12-09 · $13
  • Travel for Da Vinci Surgical System · 2019-11-19 · $19
  • Travel for Da Vinci Surgical System · 2019-11-19 · $442

Research money

Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.

Research payments by company and study
Progenics Pharmaceuticals, Inc. · Study of 18f Dcfpyl Pet Ct Imaging in Patients With Suspected Recurrence of Prostate Cancer Condor · 2019Their institution$261,302
Progenics Pharmaceuticals, Inc. · Pylarify Pet-Ct Or Pet-Mri in Men With Favorable Intermediate Risk -Fir- Prostate Cancer -Mirror · 2024Their institution$227,609
PROGENICS PHARMACEUTICALS, INC. · Pylarify Pet-Ct Or Pet-Mri in Men With Favorable Intermediate Risk -Fir- Prostate Cancer -Mirror · 2025Their institution$138,388
Progenics Pharmaceuticals, Inc. · Pylarify Pet-Ct Or Pet-Mri in Men With Favorable Intermediate Risk -Fir- Prostate Cancer -Mirror · 2025Their institution$97,089
PROGENICS PHARMACEUTICALS, INC. · The Utility of Psma-Pet Imaging for Detecting Early Metastatic Prostate Cancer in Men With High Gc Decipher Test Scores: A Sub-Aim of the Vandaam Study (Mcc #18523) · 2025Their institution$27,678
Progenics Pharmaceuticals, Inc. · Study of 18f Dcfpyl Pet Ct Imaging in Patients With Suspected Recurrence of Prostate Cancer Condor · 2020Their institution$3,990

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
75.0 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1366461667
Licence
CA A35750California A35750: Current · expires 2027-12-31
Trained
Georgetown University School of Medicine, 1979 · 47 years ago
Video visits
Lists video visits
Gender
Male
More record details
Sole proprietor
No
Medicaid ID
CA 00A357500
Taxonomy
Urology (208800000X)
Mailing address
1600 Divisadero St, 3rd Floor Uro Onc Practice, San Francisco, CA, 94115
NPI first listed
2006-07-18
NPI last updated
2008-07-24

This is when the NPI record was last certified, not a medical board exam.